{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:29:03Z","timestamp":1780086543778,"version":"3.54.0"},"reference-count":19,"publisher":"Wiley","issue":"1-2","license":[{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":84,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Environ and Mol Mutagen"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Genotoxicity of styrene monomer was evaluated in male Fischer 344 rats using the alkaline comet assay for DNA damage, micronucleus assay for cytogenetic damage and the <jats:italic>Pig\u2010a<\/jats:italic> assay for gene mutations. In a dose range finding (DRF) study, styrene was administered by oral gavage in corn oil for 28 consecutive days at 0, 100, 500, and 1000\u2009mg\/kg\/day. The bioavailability of styrene was confirmed in the DRF by measuring its plasma levels at approximately 7\u2010 or 15\u2010min following dosing. The 1000\u2009mg\/kg\/day group exceeded the maximum tolerated dose based on body weight and organ weight changes and signs of central nervous system depression. Based on these findings, doses of 0, 100, 250, and 500\u2009mg\/kg\/day (for 28 or 29\u2009days) were selected for the genotoxicity assays. Animals were sacrificed 3\u20134\u2009h after treatment on Day 28 or 29 for assessing various genotoxicity endpoints. <jats:italic>Pig\u2010a<\/jats:italic> mutant frequencies and micronucleus frequencies were determined in peripheral blood erythrocytes. The comet assay was conducted in the glandular stomach, duodenum, liver, lung, and kidney. These studies were conducted in accordance with the relevant OECD test guidelines. Oral administration of styrene did not lead to genotoxicity in any of the investigated endpoints. The adequacy of the experimental conditions was assured by including animals treated by oral gavage with the positive control chemicals ethyl nitrosourea and ethyl methane sulfonate. Results from these studies supplement to the growing body of evidence suggesting the lack of in vivo genotoxic potential for styrene.<\/jats:p>","DOI":"10.1002\/em.22590","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T09:04:51Z","timestamp":1711357491000},"page":"67-75","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Investigations on the genotoxic potential of styrene in Fischer 344 rats using multiple endpoints"],"prefix":"10.1002","volume":"65","author":[{"given":"B. Bhaskar","family":"Gollapudi","sequence":"first","affiliation":[{"name":"Toxicology Consulting  Midland Michigan USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,3,25]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/10937404.2019.1633718"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/10937400252972162"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/em.22427"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2012.03.796"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/em.22540"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2014.09.007"},{"key":"e_1_2_9_8_1","first-page":"83","volume-title":"IARC monographs on the evaluation of carcinogenic risks to humans","author":"IARC (International Agency for Research on Cancer)","year":"2019"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.2131\/jts.44.543"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/em.22278"},{"key":"e_1_2_9_11_1","volume-title":"Bioassay of styrene for possible carcinogenicity. CAS No. 100\u201042\u20104. NCI\u2010CG\u2010TR\u2010185","author":"NCI (National Cancer Institute)","year":"1979"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-2797(83)90081-9"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.3109\/10408449409020140"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1110(94)90014-0"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2004.10.001"},{"key":"e_1_2_9_16_1","unstructured":"U.S. FDA. (2005)Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. Available from:https:\/\/www.fda.gov\/media\/72309\/download[Accessed 12th March 2013]"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1998.tb01446.x"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V13.8.789.789"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-2797(01)00253-8"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrfmmm.2006.11.017"}],"container-title":["Environmental and Molecular Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/em.22590","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T10:45:37Z","timestamp":1712745937000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/em.22590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":19,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1002\/em.22590"],"URL":"https:\/\/doi.org\/10.1002\/em.22590","archive":["Portico"],"relation":{},"ISSN":["0893-6692","1098-2280"],"issn-type":[{"value":"0893-6692","type":"print"},{"value":"1098-2280","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"2024-02-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}